Pharma & Biotech

Valneva SA has encountered a significant regulatory obstacle as US health authorities suspended all distribution and sales of its recently...

Telehealth provider Hims & Hers Health, Inc. finds itself navigating a dual crisis of regulatory scrutiny and a notable lack...

While KalVista Pharmaceuticals achieved a significant regulatory milestone with European and Swiss approval for its hereditary angioedema treatment EKTERLY, investors...

Viking Therapeutics shares are entering a pivotal period as the market anticipates key developments. Following August's volatility triggered by disappointing...

The biotechnology sector is experiencing significant turbulence, with Immunocore Holdings finding itself at the center of a pronounced selloff. While...

Maravai LifeSciences Holdings Registered (A) shares continue their relentless downward trajectory, leaving shareholders to question whether a recovery is possible....

In a move signaling its serious intent to capture a share of the lucrative anti-obesity drug market, US pharmaceutical titan...

The German biotechnology firm BioNTech is navigating a critical strategic transition. Having achieved global recognition through its COVID-19 vaccine, the...

A clinical-stage biopharmaceutical company has generated significant discussion in Alzheimer's research circles with trial results suggesting unprecedented cognitive stabilization. Despite...

Replimune Group Inc. finds itself in a severe crisis, battling significant regulatory setbacks and a growing wave of shareholder litigation....